Executive Summary
CrowdStrike has filed an IPR petition seeking to invalidate GoSecure’s 9,106,697 patent covering virtual‑machine‑based malware detection. The petition argues obviousness over Capalik combined with King, Pike, and Farley, and opposes discretionary denial.
Related Cases
LifeVac, LLCvsDCStar Inc.
LifeVac, LLC's IPR petition against DCStar Inc. was denied by the PTAB after the Board found insufficient evidence of unpatentability. The decision hinged on a prior art challenge regarding an inventor-originated public disclosure (IDEAR) that predated one key reference.
Motorola Solutions, Inc. et al.vsStellar, LLC
Motorola Solutions successfully petitioned the PTAB for institution of IPR against Stellar, LLC's patent (8310540), challenging all 19 claims based on obviousness. The Board found a reasonable likelihood that combining prior art references like Yerazunis and Fiore would render the claimed features unpatentable.
Activision Blizzard, Inc.vsMilestone Entertainment, LLC
Milestone Entertainment’s preliminary response argues that Activision Blizzard’s IPR petition fails because the cited prior art does not disclose the required game‑processor features and one reference is not prior art. The Board is urged to deny institution.
Ascentcare Dental Products, Inc.vsSolmetex, LLC
Ascentcare Dental Products has filed an IPR petition seeking to invalidate 25 claims of Solmetex’s intraoral device patent, alleging obviousness over several prior‑art references. The petition outlines eight grounds and requests institution of the review.
MIM Software Inc. et al.vsProgenics Pharmaceuticals, Inc. et al.
The PTAB denied MIM Software's request to institute IPR against Progenics Pharmaceuticals regarding a medical image analysis patent. The denial was based on Petitioner's failure to properly construe the key term 'risk map,' proposing multiple ambiguous definitions without adequate justification.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.